Detumomab(145832-33-3)
- Name: Detumomab
- Synonyms:
- Molecular Formula:
- Molecular Weight:0
- CAS Registry Number:145832-33-3
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.145832-33-3 DetuMoMab
Assay:99% Appearance:White powder Package:25KGS/Drum Storage:Room temperature Transportation:BY SEA Application:API锛孭harmaceutical intermediates
Min. Order:1Gram
Supplier:HENAN NEW BLUE CHEMICAL CO.,LTD [
China (Mainland)]
CAS No.145832-33-3 Detumomab
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)]
CAS No.145832-33-3 Detumomab
Assay:99% Application:api
Min. Order:0
Supplier:Zibo Hangyu Biotechnology Development Co., Ltd [
China (Mainland)]
CAS No.145832-33-3 Detumomab
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:Detumomab
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)]

Other Product
- 1670-94-6/Methoxycarbonylglycine 4-nitrophenyl ester
- 101771-75-9/6,11-dimethyl-3-(2-phenylethyl)-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine
- 13167-36-7/2-Propenoic acid, 2,3-dichloro- (9CI)
- 65859-54-3/Butanedioic acid, methylene-, polymer with butyl 2-propenoate, 2-methyl-2-propenoic acid and 2-propenenitrile
- 68130-69-8/1-Propanamine, 3-(C16-22-alkyloxy) derivs.
- 60569-64-4/tetraoxidosilane
- 912-38-9/9beta,11beta-epoxy-17,21-dihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 21-acetate
- 83465-22-9/Valiolamine
- 139-43-5/1,2,3-propanetriyl tris[12-(acetoxy)octadecanoate]
- 23333-91-7/octahydro-4,8a-dimethyl-4a(2H)-naphthol
- 7299-89-0/bis(2-ethylbutyl) phthalate
- 56748-23-3/Ensanchomycin
- 3033-92-9/(2E)-1-(3-hydroxyphenyl)-3-phenylprop-2-en-1-one
- 122456-25-1/6-methoxy-4-methyl-1-(2-methylphenyl)-2,3-dihydro-1H-pyrrolo[3,2-c]quinoline
- 489-17-8/4-FLUORO-2-METHYL-BENZENESULFONAMIDE
- 142449-72-7/4,6-Octadiyn-3-ol,8-(3-heptyloxiranyl)-, acetate (9CI)
- 68688-84-6/3-Methylcholanthrene-cis-2a,3-diol
- 6332-80-5/N-[4-(1,2lambda~4~,3-benzodithiazol-2-yl)phenyl]acetamide
- 145832-33-3/Detumomab
- 74509-14-1/2-formyl-5-(hydroxymethyl)pyrrole-1-norleucine
- 75067-09-3/2-ethenylidene-2H-indene
- 77966-51-9/2-[(2-chloro-6-methylphenyl)(methyl)amino]-N,N-diethyl-2-oxoethanaminium chloride
- 7474-64-8/2,3-diphenyl-2,3-dihydro-1H-inden-1-one
- 72828-51-4/Iron, complexes with diazotized 2-amino-4,6-dinitrophenol coupled with diazotized 2-((4-aminophenyl)amino)-5-nitrobenzenesulfonic monosodium salt and 3-((2,4-dihydroxyphenyl)azo)-4-hydroxybenzenesulfonic acid monosodium salt
- 103395-69-3/Glycine, L-g-glutamyl-S-1-naphthalenyl-L-cysteinyl-(9CI)
- 925-83-7/Sebacic dihydrazide
- 101651-98-3/3-(7-chloro-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)-N-ethyl-N-(2-hydroxyethyl)propan-1-aminium chloride
- 71160-14-0/diethyl 2,6-dimethyl-4-[(E)-2-(5-nitrofuran-2-yl)ethenyl]-1,4-dihydropyridine-3,5-dicarboxylate
- 116786-77-7/{2-[(E)-2-(4-chlorophenyl)ethenyl]-4-(4-fluorophenyl)-1,3-thiazol-5-yl}acetic acid
- 42779-87-3/[1-(3-chloro-2-methylphenyl)-2,5-dimethyl-1H-pyrrol-3-yl]acetic acid